| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Jan 03, 2024 | Sale | $29.46 | 19,223 | 566,310 | 846,486 | Jan 05, 2024, 04:51 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Jan 04, 2023 | Sale | $37.21 | 6,673 | 248,302 | 766,825 | Jan 06, 2023, 05:32 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Jan 01, 2022 | Sale | $112.25 | 2,493 | 279,852 | 724,660 | Mar 04, 2022, 09:07 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Aug 30, 2021 | Sale | $155.95 | 38,804 | 6,051,353 | 756,054 | Sep 01, 2021, 08:21 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Sep 01, 2021 | Option Exercise | $21.62 | 44,735 | 967,000 | 764,040 | Sep 01, 2021, 08:21 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Aug 31, 2021 | Option Exercise | $14.58 | 37,833 | 551,605 | 757,138 | Sep 01, 2021, 08:21 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Sep 01, 2021 | Sale | $170.00 | 44,735 | 7,604,950 | 719,305 | Sep 01, 2021, 08:21 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Aug 30, 2021 | Option Exercise | $14.23 | 38,804 | 552,031 | 758,109 | Sep 01, 2021, 08:21 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Aug 31, 2021 | Sale | $155.00 | 37,833 | 5,864,115 | 719,305 | Sep 01, 2021, 08:21 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Aug 23, 2021 | Option Exercise | $13.40 | 27,139 | 363,663 | 746,444 | Aug 25, 2021, 04:14 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Aug 23, 2021 | Sale | $152.01 | 27,139 | 4,125,416 | 727,570 | Aug 25, 2021, 04:14 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Aug 19, 2021 | Option Exercise | $13.40 | 22,682 | 303,939 | 741,987 | Aug 20, 2021, 06:14 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Aug 19, 2021 | Sale | $151.28 | 22,682 | 3,431,398 | 732,261 | Aug 20, 2021, 06:14 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Apr 13, 2021 | Option Exercise | $11.16 | 25,937 | 289,506 | 719,305 | Apr 15, 2021, 08:50 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Feb 05, 2021 | Option Exercise | $13.40 | 40,000 | 536,000 | 654,803 | Feb 09, 2021, 08:36 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Feb 05, 2021 | Sale | $67.66 | 22,942 | 1,552,185 | 646,760 | Feb 09, 2021, 08:36 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Feb 09, 2021 | Option Exercise | $6.83 | 56,718 | 387,384 | 688,579 | Feb 09, 2021, 08:36 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Feb 09, 2021 | Sale | $75.00 | 28,043 | 2,103,225 | 660,536 | Feb 09, 2021, 08:36 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Feb 03, 2021 | Sale | $72.54 | 67,856 | 4,922,490 | 614,803 | Feb 03, 2021, 09:39 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Feb 01, 2021 | Option Exercise | $13.69 | 200,000 | 2,737,600 | 598,814 | Feb 03, 2021, 09:39 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Feb 01, 2021 | Sale | $64.00 | 109,889 | 7,032,905 | 587,714 | Feb 03, 2021, 09:39 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Feb 03, 2021 | Option Exercise | $17.68 | 117,060 | 2,069,793 | 651,661 | Feb 03, 2021, 09:39 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Jan 05, 2021 | Sale | $55.86 | 6,239 | 348,511 | 475,488 | Jan 05, 2021, 09:24 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Nov 27, 2020 | Sale | $38.57 | 35,000 | 1,350,000 | 467,352 | Nov 27, 2020, 09:00 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Nov 27, 2020 | Option Exercise | $16.17 | 35,000 | 566,100 | 487,352 | Nov 27, 2020, 09:00 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Nov 25, 2020 | Option Exercise | $6.83 | 50,000 | 341,500 | 517,352 | Nov 25, 2020, 08:02 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Nov 25, 2020 | Sale | $36.00 | 50,000 | 1,800,000 | 467,352 | Nov 25, 2020, 08:02 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Nov 16, 2020 | Option Exercise | $14.58 | 20,000 | 291,600 | 487,352 | Nov 18, 2020, 07:56 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Nov 16, 2020 | Sale | $34.00 | 20,000 | 680,000 | 467,352 | Nov 18, 2020, 07:56 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Nov 04, 2020 | Option Exercise | $6.83 | 50,000 | 341,500 | 517,352 | Nov 06, 2020, 04:38 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Nov 04, 2020 | Sale | $26.00 | 50,000 | 1,300,000 | 467,352 | Nov 06, 2020, 04:38 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Oct 07, 2020 | Option Exercise | $6.83 | 5,000 | 34,150 | 472,352 | Oct 09, 2020, 04:14 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M | President and CEO | Oct 07, 2020 | Sale | $21.83 | 5,000 | 109,150 | 467,352 | Oct 09, 2020, 04:14 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M. | President and CEO | Sep 01, 2020 | Option Exercise | $6.83 | 5,000 | 34,150 | 472,352 | Sep 03, 2020, 04:15 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M. | President and CEO | Sep 01, 2020 | Sale | $21.83 | 5,000 | 109,150 | 467,352 | Sep 03, 2020, 04:15 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M. | President and CEO | Aug 06, 2020 | Option Exercise | $6.83 | 5,000 | 34,150 | 472,352 | Aug 07, 2020, 07:29 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M. | President and CEO | Aug 06, 2020 | Sale | $21.83 | 5,000 | 109,150 | 467,352 | Aug 07, 2020, 07:29 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M. | President and CEO | Jul 01, 2020 | Option Exercise | $6.83 | 5,000 | 34,150 | 472,352 | Jul 02, 2020, 04:10 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M. | President and CEO | Jul 01, 2020 | Sale | $21.83 | 5,000 | 109,150 | 467,352 | Jul 02, 2020, 04:10 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M. | President and CEO | Jun 03, 2020 | Sale | $21.83 | 5,000 | 109,150 | 467,352 | Jun 05, 2020, 05:18 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M. | President and CEO | Jun 03, 2020 | Option Exercise | $6.83 | 5,000 | 34,150 | 472,352 | Jun 05, 2020, 05:18 PM | |
| IQV | IQVIA HOLDINGS INC. | LEONARD JOHN M. | Director | Dec 20, 2019 | Option Exercise | $64.77 | 20,200 | 1,308,254 | 28,452 | Dec 26, 2019, 04:33 PM | |
| IQV | IQVIA HOLDINGS INC. | LEONARD JOHN M. | Director | Dec 20, 2019 | Sale | $153.00 | 20,200 | 3,090,600 | 18,352 | Dec 26, 2019, 04:33 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M. | President and CEO | May 14, 2018 | Sale | $24.00 | 8,400 | 201,600 | 0 | May 15, 2018, 08:43 PM | |
| NTLA | Intellia Therapeutics, Inc. | LEONARD JOHN M. | EVP, R&D | Jun 01, 2017 | Option Exercise | $12.06 | 8,400 | 101,322 | 8,400 | Jun 05, 2017, 07:55 AM | |
| CMRX | CHIMERIX INC | LEONARD JOHN M. | Director | Sep 15, 2016 | Sale | $5.03 | 5,000 | 25,162 | 0 | Sep 16, 2016, 06:46 PM | |
| CMRX | CHIMERIX INC | LEONARD JOHN M. | Director | Aug 21, 2015 | Buy | $47.38 | 1,000 | 47,380 | 1,000 | Aug 25, 2015, 02:25 PM | |
| CMRX | CHIMERIX INC | LEONARD JOHN M. | Director | Nov 05, 2014 | Buy | $29.00 | 4,000 | 116,000 | 4,000 | Nov 06, 2014, 04:50 PM | |
| ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientific Officer | Mar 15, 2013 | Sale | $38.45 | 46,700 | 1,795,615 | 107,320 | Mar 19, 2013, 05:13 PM | |
| ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientific Officer | Mar 15, 2013 | Option Exercise | $28.86 | 46,700 | 1,347,893 | 154,020 | Mar 19, 2013, 05:13 PM | |
| ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientific Officer | Mar 08, 2013 | Sale | $37.51 | 27,949 | 1,048,432 | 130,964 | Mar 12, 2013, 05:08 PM | |
| ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientific Officer | Feb 28, 2013 | Option Exercise | $36.73 | 9,407 | 345,519 | 135,269 | Mar 04, 2013, 05:07 PM | |
| ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientific Officer | Feb 19, 2013 | Option Exercise | $37.58 | 25,345 | 952,465 | 148,981 | Feb 21, 2013, 05:04 PM | |
| ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientific Officer | Feb 19, 2013 | Option Exercise | $27.29 | 29,650 | 809,267 | 174,326 | Feb 21, 2013, 05:04 PM | |
| ABBV | AbbVie Inc. | LEONARD JOHN M. | SVP, Chief Scientific Officer | Feb 19, 2013 | Option Exercise | $37.58 | 7,982 | 299,964 | 144,676 | Feb 19, 2013, 07:04 PM |
Menu